Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru by Devan Jaganath et al.
Jaganath et al. Respiratory Research  (2015) 16:40 
DOI 10.1186/s12931-015-0198-2RESEARCH Open AccessPrevalence of chronic obstructive pulmonary
disease and variation in risk factors across four
geographically diverse resource-limited settings
in Peru
Devan Jaganath1,2, J Jaime Miranda3,4, Robert H Gilman2, Robert A Wise1, Gregory B Diette1, Catherine H Miele1,
Antonio Bernabe-Ortiz3, William Checkley1* and CRONICAS Cohort Study GroupAbstract
Background: It is unclear how geographic and social diversity affects the prevalence of chronic obstructive
pulmonary disease (COPD). We sought to characterize the prevalence of COPD and identify risk factors across four
settings in Peru with varying degrees of urbanization, altitude, and biomass fuel use.
Methods: We collected sociodemographics, clinical history, and post-bronchodilator spirometry in a randomly
selected, age-, sex- and site-stratified, population-based sample of 2,957 adults aged ≥35 years (median age was
54.8 years and 49.3% were men) from four resource-poor settings: Lima, Tumbes, urban and rural Puno. We defined
COPD as a post-bronchodilator FEV1/FVC < 70%.
Results: Overall prevalence of COPD was 6.0% (95% CI 5.1%–6.8%) but with marked variation across sites: 3.6% in
semi-urban Tumbes, 6.1% in urban Puno, 6.2% in Lima, and 9.9% in rural Puno (p < 0.001). Population attributable
risks (PARs) of COPD due to smoking ≥10 pack-years were less than 10% for all sites, consistent with a low
prevalence of daily smoking (3.3%). Rather, we found that PARs of COPD varied by setting. In Lima, for example, the
highest PARs were attributed to post-treatment tuberculosis (16% and 22% for men and women, respectively). In rural
Puno, daily biomass fuel for cooking among women was associated with COPD (prevalence ratio 2.22, 95% CI
1.02–4.81) and the PAR of COPD due to daily exposure to biomass fuel smoke was 55%.
Conclusions: The burden of COPD in Peru was not uniform and, unlike other settings, was not predominantly
explained by tobacco smoking. This study emphasizes the role of biomass fuel use, and highlights pulmonary
tuberculosis as an often neglected risk factor in endemic areas.
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The chronic disease epidemic has placed a large burden
on morbidity and mortality in low and middle-income
countries. The 2010 Global Burden of Disease study in-
dicated that 54% of all disability-adjusted life years lost
worldwide were attributed to non-communicable, chronic
diseases [1]. Chronic obstructive pulmonary disease
(COPD), characterized by lower airway inflammation* Correspondence: wcheckl1@jhmi.edu
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unless otherwise stated.and damage that impairs airflow, is the third leading
cause of death worldwide, with a global prevalence esti-
mate of 10% [2,3]. Risk factors for COPD reported in the
literature include smoking, outdoor pollution, indoor pol-
lution, occupational dust exposure, asthma, past history of
tuberculosis, and genetics [4-6].
Low- and middle-income countries currently share the
greatest proportion of chronic respiratory disease world-
wide [7,8]. Management guidelines and public health ef-
forts specific to these settings are critical to prevention
and care for COPD [9]. However, healthcare infrastructure
for COPD surveillance and management in resource-al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and BOLD studies demonstrated substantial geographic
variation in COPD prevalence, and the PURE study simi-
larly found that lung function differed greatly by region
[6,10] This heterogeneity underscores the importance of
investigating local factors that shape the burden of COPD,
especially in resource-limited settings that contain con-
siderable diversity in culture, socioeconomic status, and
environment.
In Latin America, the PLATINO and PREPOCOL stud-
ies assessed the burden of COPD and highlighted risk fac-
tors such as tobacco smoking across their study settings
[11-13]. However, there is a critical gap in our understand-
ing of COPD across diverse geographical and social set-
tings. Peruvians live in densely populated urban areas as
well as rural village settings, along the coast and in the
Andes Mountains, and we sought to characterize variation
in prevalence and risk factors for COPD.
Methods
Setting
The CRONICAS study is a longitudinal, population-based
study aimed to determine the prevalence of chronic pul-
monary and cardiovascular diseases across four disparate
regions in Peru. The study has been described in detail
elsewhere [14] and involved collection of sociodemo-
graphic and clinical data from adults aged ≥35 years in
four diverse populations in Peru. The four settings under
study varied based on degrees of urbanization, living at
high altitude, prevalence of daily biomass fuel use. Pampas
de San Juan de Miraflores is a dense, urbanized commu-
nity 25 kilometers south of central Lima and consists pri-
marily of Andean immigrants. Tumbes is a semi-urban,
sea-level community in northern Peru within an agrarian
setting and little to no vehicular traffic. Puno is a south-
western city in the Andes, located on the shores of Lake
Titicaca at 3,825 meters above sea-level. Within Puno
there were two separate sites: an urban setting located at
the city center and a rural setting made up of inhabitants
from surrounding communities [15].
Design
We enrolled an age (35–44, 45–54, 55–64 and ≥65 years),
sex and site stratified sample of eligible subjects. Recruit-
ment began in September 2010 and was conducted until
about 1,000 participants with complete information per
site were enrolled. Only one participant per household
was enrolled. In Puno, we stratified recruitment to include
500 participants each from the urban and rural settings.
Inclusion criteria were age ≥35 years, a full-time resident
in the specified setting, and capacity to understand proce-
dures and consent to the study. Exclusion criteria were
pregnancy, physical disability that prevented measurement
of blood pressure or anthropometry, or active pulmonarytuberculosis. All participants provided verbal informed
consent after our research team read the entire informed
consent document to them and any questions were an-
swered. Informed consents were verbal because of high
illiteracy rates. The study was approved by the Institutional
Review Boards of Universidad Peruana Cayetano Heredia
and A.B. PRISMA, in Lima, Peru, and the Johns Hopkins
Bloomberg School of Public Health in Baltimore, USA.
Data collection
Participants responded to a questionnaire on sociode-
mographics, smoking history, respiratory symptoms, past
medical history, and family history of disease. A detailed
questionnaire also evaluated frequency and duration of
cooking with biomass fuels. Field workers measured
weight and height in triplicate. Spirometry was con-
ducted using the Easy-On-PC spirometer (ndd, Zurich,
Switzerland) before and after 200 mcg of inhaled salbu-
tamol via a spacer. Trained technicians measured pre- and
post-bronchodilator spirometry in participants following
joint American Thoracic Society and European Respiratory
Society (ATS/ERS) guidelines [16]. We adapted a standard-
ized grading system for quality control, review and inter-
pretation [17]. Participants with low quality spirometry
were asked to repeat the test on another day for a total of
three attempts. Overall, 96% of all tests achieved an ac-
ceptable result and 95% met ATS/ERS criteria.
Definitions
We defined COPD according to the Global initiative
for chronic Obstructive Lung Disease (GOLD) criteria
as a post-bronchodilator FEV1/FVC < 70% [18]. We used
percent-predicted post-bronchodilator FEV1 values to as-
sess severity by GOLD staging. Since there are no estab-
lished reference equations for Peruvians, we utilized both
the NHANES III Mexican-Americans [19] and the Global
Lungs Initiative (GLI) mixed ethnic population equations
[20]. In a sensitivity analysis, we also defined COPD as
post-bronchodilator FEV1/FVC less than the lower limit of
normal by age and sex according to GLI mixed ethnic popu-
lation equations [20]. We defined a post-bronchodilator
response as an improvement of greater than 12% and
200 mL in post-bronchodilator vs. pre-bronchodilator
forced expiratory volumes. We defined high altitude as ei-
ther living in urban or rural Puno versus sea level as either
living in Lima or Tumbes. We derived a wealth index
based on assets, household facilities and household in-
come [21].
Biostatistical methods
The primary objectives of this analysis were to estimate
the prevalence of COPD and identify variation in risk
factors across our settings. We estimated the prevalence
of COPD and corresponding 95% confidence intervals
Figure 1 Flowchart of participants.
Jaganath et al. Respiratory Research  (2015) 16:40 Page 3 of 9(CI) by site using standard methods. We compared base-
line characteristics and spirometry results across sites
using chi-squared or Fisher exact tests for categorical
variables and Wilcoxon rank sum or Kruskal-Wallis tests
for continuous variables. We used sex-stratified multi-
variable Poisson regressions [22] to model the preva-
lence of COPD as a function of age, living at high
altitude, degree of urbanization, smoking for at least 10
pack-years, tertiles of wealth index, history of post-
treatment pulmonary tuberculosis, history of asthma,
and daily use of biomass fuels for cooking. We used the
Huber-White method to correct the variance-covariance
matrix for correlated responses by site [23]. We did not
include indicator variables for site as fixed effects in the
multivariable regression model because of collinearity
with selected environmental risk factors (Table 1). Popu-
lation attributable risks for COPD due to risk factors
were calculated as PAR ¼ p PR−1ð Þ1þp PR−1ð Þ ; where p was the
prevalence of exposure and PR was the adjusted preva-
lence ratio obtained from multivariable Poisson regres-
sion. Twenty-seven participants with missing values (<1%)
of the 2,957 were excluded from multivariable analysis.
In an ancillary analysis, we assessed inter-test reliabil-
ity for severity staging when using NHANES III vs.
GLI percent predicted values both by percent agree-
ment and the kappa statistic. Analyses were performed in
STATA 12 (StataCorp, College Station, Texas, USA) and R
(www.r-project.org).Results
Participant characteristics
We enrolled 4,325 participants of whom 3,601 (83%)
had complete questionnaires (Figure 1). In total, 2,957
participants had complete spirometry data. We did not
identify differences in age (p = 0.72), sex (p = 0.15), daily
smoking (p = 0.80), self-reported history of post-treatment
pulmonary tuberculosis (p = 0.88) and asthma (p = 0.25)
or biomass fuel use (p = 0.22) between participants with
and without spirometry data in an analysis adjusted for
site.
Among the 2,957 participants, median age was 54.8 years
and 49.3% were men (Table 2). Daily smoking was low atTable 1 Selected environmental risk factors by setting
Setting Urbanization Daily use of
biomass fuels
Altitude
Lima Urban Rare Sea level
Tumbes Semi-urban Moderately prevalent Sea level
Puno, urban Urban Rare 3,825 meters above
sea level
Puno, rural Rural Highly prevalent 3,825 meters above
sea level3.3% across all sites, and ranged from 0.2% in rural Puno
to 5.6% in Tumbes (p < 0.001). Median pack-years among
smokers was 0.2 (IQR 0.01–1.53). When stratified by sex,
we found that 79 (5.5%) men reported smoking daily com-
pared to only 18 (1.2%) women (p < 0.001). Overall, 2.9%
of participants reported a history of post-treatment
pulmonary tuberculosis and 3.9% reported a history of
asthma. Participants in Lima reported having the highest
prevalences of post-treatment pulmonary tuberculosis and
asthma. Eight (0.4%) individuals reported having a family
history of COPD.
Non-urban settings had the highest proportions of
biomass fuel use: ≥97% of participants in rural Puno re-
ported that biomass fuels were used daily for cooking in
their household, and 91% reported cooking indoors. A
total of 23% reported daily biomass fuel use in Tumbes,
but 53% reported cooking indoors. Women were more
likely to be the household cook: 1,432 (95.7%) reported
that they cooked vs. 862 (59.4%) males (p < 0.001).
Variation in lung function measurements
We compared post-bronchodilator lung function across
sites in both men (Table 3) and women (Table 4). Living
at high altitude (urban or rural Puno) vs. at sea level
(Lima or Tumbes) was associated with having higher aver-
age FEV1 values in both males (3.5 L vs. 3.3 L; p < 0.001)
and females (2.4 L vs. 2.3 L; p < 0.001), higher average
FVC values in both males (4.4 L vs. 4.1 L; p < 0.001) and
females (3.0 L vs. 2.7 L; p < 0.001), but lower average
FEV1/FVC values in both males (78.0% vs. 80.2%; p <
0.001) and females (79.9% vs. 82.8%; p < 0.001).
Table 2 Participant characteristics across four sites in Peru (p-values calculated using Kruskal-Wallis tests for
continuous variables, and chi-squared or Fisher exact tests for categorical variables)
Lima Urban Puno Rural Puno Tumbes Overall P
998 (33.8) 507 (17.2) 506 (17.1) 946 (32.0) 2957
Age in years, median (IQR) 54.7 (45.5, 64.0) 54.8 (44.9, 64.5) 54.8 (45.1, 63.9) 54.9 (45.0, 64.8) 54.8 (45.2, 64.3) 0.87
Number of males (%) 492 (49.3) 250 (49.3) 240 (47.4) 475 (50.2) 1457 (49.3) 0.80
Height in m, median (IQR) 1.54. (1.49, 1.61) 1.57 (1.50, 1.63) 1.55 (1.49, 1.62) 1.58 (1.52, 1.65) 1.56 (1.50, 1.63) <0.001
BMI >30 kg/m2, n (%) 324 (32.5) 133 (26.4) 54 (10.8) 299 (31.6) 810 (27.5) <0.001
Daily smoking, n (%) 32 (3.2) 11 (2.2) 1 (0.2) 53 (5.6) 97 (3.3) <0.001
Rural origin, n (%) 510 (51.2) 103 (20.5) 481 (96.4) 285 (30.2) 1379 (46.9) <0.001
Wealth index, n (%)
Low 119 (11.9) 120 (23.9) 356 (70.4) 307 (32.5) 902 (30.6) <0.001
Middle 366 (36.7) 129 (25.7) 136 (26.9) 387 (40.9) 1018 (34.5)
High 513 (51.4) 254 (50.5) 14 (2.8) 252 (26.6) 1033 (35.0)
Exposures, n (%)
Daily use of biomass fuels for cooking 61 (6.1) 25 (5.0) 483 (96.6) 221 (23.4) 790 (26.8) <0.001
Cooks indoors 573 (57.8) 436 (86.7) 453 (90.8) 497 (53.0) 1959 (66.8) <0.001
Clinical, (%)
History of tuberculosis 69 (6.9) 3 (0.6) 7 (1.4) 7 (0.7) 86 (2.9) <0.001
History of asthma 82 (8.2) 13 (2.6) 3 (0.6) 16 (1.7) 114 (3.9) <0.001
Family History of asthma 146 (24.7) 18 (3.6) 8 (1.6) 51 (7.9) 223 (10.0) <0.001
Family History of COPD 4 (0.7) 4 (0.8) 0 0 8 (0.4) 0.04
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The overall prevalence of COPD was 6% with marked
variation by sex and across sites. When stratified by sex,
we found that 123 (8.4%) men and 54 (3.6%) women had
COPD (p < 0.001). Across sites, prevalence ranged from
3.6% in Tumbes to 9.9% in rural Puno (Table 5). Partici-
pants in urban Puno had a similar prevalence of COPD
than did those in Lima (p = 1.00) but a lower prevalence
than participants in rural Puno (p = 0.04). This trendTable 3 Median and interquartile range of post-bronchodilato
Function Initiative (GLI) mixed ethnic population and Hankin
(p-values calculated using Kruskal-Wallis tests)
Lima (n = 492) Urban Puno (n
FEV1 (L) 3.4 (2.9–3.7) 3.5 (3.0–4.0)
FVC (L) 4.2 (3.7–4.7) 4.4 (3.8–5.1)
FEV1/height
2 (L/m2) 1.3 (1.1–1.4) 1.3 (1.1–1.4)
FVC/height2 (L/m2) 1.6 (1.4–1.8) 1.7 (1.5–1.9)
FEV1/FVC (%) 80.0 (75.4–83.4) 78.4 (74.9–82.3)
Percent Predicted FEV1 (%)
GLI 117.9 (107.5–129.8) 119.9 (109.9–130
NHANES III 113.3 (102.0–124.7) 114.6 (105.2–124
Percent Predicted FVC (%)
GLI 120.1 (108.9–130.5) 123.0 (112.8–134
NHANES III 109.7 (99.8–119.5) 112.3 (104.7–123was similar for both men and women. Staging by GOLD
criteria showed that the majority of cases were either Stage
I or II and similar across sites, regardless of GLI mixed
ethnic population or NHANES III Mexican American ref-
erence equations (93.8% agreement, kappa = 0.85). The
only five severe stage cases of COPD (i.e., GOLD stage III)
occurred in Lima and Tumbes, and all were male. We also
found that post-bronchodilator response (i.e., reversibility)
did not differ for males and females across sites amongr lung function values in men using the Global Lungs
son NHANES III Mexican-American reference equations
= 250) Rural Puno (n = 240) Tumbes (n = 475) P
3.5 (2.9–3.9) 3.2 (2.8–3.6) <0.001
4.4 (3.9–5.0) 4.0 (3.4–4.4) <0.001
1.3 (1.1–1.5) 1.2 (1.0–1.3) <0.001
1.7 (1.5–1.9) 1.5 (1.3–1.6) <0.001
77.8 (73.6–81.0) 80.6 (77.4–84.0) <0.001
.2) 121.7 (111.5–133.9) 107.7 (97.7–117.5) <0.001
.2) 117.0 (106.7–129.0) 102.4 (92.6–112.0) <0.001
.3) 126.2 (114.4–139.3) 107.7 (98.3–116.0) <0.001
.3) 116.1 (105.6–128.1) 98.7 (90.1–107.0) <0.001
Table 4 Median and interquartile range of post-bronchodilator lung function values in women using the Global Lungs
Function Initiative (GLI) mixed ethnic population and Hankinson NHANES III Mexican-American reference equations
(p-values calculated using Kruskal-Wallis tests)
Lima (n = 506) Urban Puno (n = 257) Rural Puno (n = 266) Tumbes (n = 471) P
FEV1 (L) 2.3 (2.0–2.6) 2.4 (2.0–2.8) 2.4 (2.0–2.8) 2.2 (1.9–2.5) <0.001
FVC (L) 2.8 (2.4–3.2) 3.0 (2.5–3.5) 3.0 (2.5–3.5) 2.6 (2.3–2.9) <0.001
FEV1/height
2 (L/m2) 1.0 (0.9–1.2) 1.1 (0.9–1.2) 1.1 (0.9–1.2) 0.9 (0.8–1.1) <0.001
FVC/height2 (L/m2) 1.3 (1.1–1.4) 1.3 (1.1–1.5) 1.3 (1.2–1.5) 1.1 (1.0–1.3) <0.001
FEV1/FVC (%) 82.7 (79.3–85.3) 80.5 (77.0–83.6) 79.6 (75.6–82.5) 83.0 (79.7–86.1) <0.001
Percent predicted FEV1 (%)
GLI 112.0 (102.1–123.7) 115.2 (106.1–126.5) 113.9 (102.3–126.0) 103.1 (93.8–112.0) <0.001
NHANES III 106.2 (96.9–117.2) 110.4 (100.7–119.7) 107.5 (96.5–118.4) 96.5 (88.5–105.5) <0.001
Percent predicted FVC (%)
GLI 111.7 (100.3–122.1) 119.2 (106.4–129.2) 116.9 (104.7–128.3) 101.1 (93.2–109.9) <0.001
NHANES III 103.4 (92.8–113.0) 110.5 (98.3–119.1) 107.6 (96.7–118.4) 93.1 (85.5–100.8) <0.001
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across sites for individuals without COPD and rural Puno
had the highest proportion of participants with a post-
bronchodilator response.
When using the lower limit of normal for FEV1/FVC
based on GLI reference equations, we found that there
were 142 cases of COPD (prevalence of 4.8%; 95% CI 4.0
to 5.6). By site, the prevalence was 57 (5.7%) in Lima, 25
(4.9%) in urban Puno, 43 (8.5%) in rural Puno, and 17
(1.8%) in Tumbes. Overall, this corresponded to 97%
agreement with the fixed ratio definition, and a kappa of
0.69.
Risk factors associated with COPD
Single variable analysis suggested that age, sex, altitude, smok-
ing, urbanization, socioeconomic status, post-treatment tuber-
culosis, asthma, and daily biomass fuel use may be associatedTable 5 Prevalence of COPD across four sites in Peru using th
population and Hankinson NHANES III Mexican-American refe
or Fisher exact tests)
Lima U
(n = 998) (n
COPD prevalence (95% CI) 6.2 (4.7–7.7) 6.
GOLD class by GLI, n (%)
I 43 (69.4) 26
II 16 (25.8) 5
III 3 (4.8) 0
GOLD class by NHANES III, n (%)
I 42 (67.7) 24
II 17 (27.4) 7
III 3 (4.8) 0
Post-bronchodilator response in COPD, n (%) 22 (36%) 8
Post-bronchodilator response in non-COPD, n (%) 99 (11%) 57with COPD prevalence (Table 6). In sex-stratified multi-
variable analyses (Table 7), older vs. younger individuals
and those who lived at a higher altitude vs. at sea level
had greater prevalence of COPD. Moreover, both a his-
tory of post-treatment tuberculosis and asthma were posi-
tively associated with COPD. Smoking for at least 10
pack-years was associated with COPD in males, and was
marginally significant in females. We found that females
but not males who lived in a rural setting were more likely
to have COPD compared to an urban setting, while living
in semi-urban region was associated with a decreased like-
lihood of COPD compared to an urban setting for both
sexes.
Population attributable risks of COPD
We calculated PARs of COPD across sites and by sex due to
daily biomass fuel use, smoking at least 10 pack-years, post-e Global Lungs Function Initiative (GLI) mixed ethnic
rence equations (p-values calculated using chi-squared
rban Puno Rural Puno Tumbes Overall P
= 507) (n = 506) (n = 946)
1 (4.0–8.2) 9.9 (7.3–12.5) 3.6 (2.4–4.8) 6.0 (5.1–6.8) <0.001
(83.9) 38 (76.0) 21 (61.7) 128 (72.3) 0.29
(16.1) 12 (24.0) 11 (32.4) 44 (24.9)
0 2 (5.9) 5 (2.8)
(77.4) 38 (76.0) 19 (55.9) 123 (69.5) 0.26
(22.6) 12 (24.0) 13 (38.2) 49 (27.8)
0 2 (5.9) 5 (2.8)
(26%) 13 (26%) 9 (27%) 52 (29%) 0.63
(12%) 78 (17%) 73 (8%) 307 (11%) <0.001
Table 6 Single variable factors associated with COPD prevalence across four sites in Peru (n = 2957)
Prevalence ratio 95% CI P
Age (per 10 years) 1.93 1.71–2.17 <0.001
Male vs. Female Sex 2.35 1.61–3.42 <0.001
Height (cm) 1.01 0.99–1.02 0.27
High Altitude vs. sea-level 1.61 0.92–2.82 0.10
≥10 pack-years of smoking 2.51 1.65–3.80 <0.001
Urbanization
Urban 1.00
Semi-Urban 0.58 0.57–0.58 <0.001
Rural 1.57 1.56–1.59 <0.001
Post-treatment pulmonary tuberculosis 4.27 3.09–5.88 <0.001
Asthma 2.49 1.59–3.88 <0.001
Biomass use at least once daily 1.68 1.25–2.25 0.001
Wealth Index
Low 1.00
Middle 0.81 0.50–1.30 0.38
High 0.53 0.33–0.87 0.01
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Daily biomass fuel use notably increased PAR of COPD
among women based on degree of urbanization, with 23%
in semi-urban Tumbes and 55% in rural Puno. PAR of
COPD due to smoking ≥10 pack years was less than 10%
for all sites, and was greatest for men in Tumbes at 7%.
Post-treatment pulmonary tuberculosis contributed the
most to COPD in Lima, where PAR of COPD was 16% in
men and 23% in women. PAR of COPD due to asthma
was similarly highest in Lima, with 6% in men and 12% in
women.Table 7 Multivariable regression of risk factors associated wit
Males (n = 1443)
Prevalence ratio 95%
Age (per 10 years) 1.65 1.42
High altitude vs. sea-level 1.13 1.06





Post-treatment pulmonary tuberculosis 3.12 2.02
Asthma 2.16 1.11





In this multi-center, population-based study of adult par-
ticipants in Peru, we found considerable variation in
lung function and prevalence of COPD among four
resource-poor sites with varying degrees of urbanization,
altitude, and biomass fuel use. While daily smoking
prevalence was low across sites, population attributable
risks of COPD suggest that daily biomass fuel use con-
tributed to an important proportion of COPD in rural
settings, whereas a history of post-treatment pulmonary
tuberculosis and asthma were important risk factors inh COPD prevalence in Peru, stratified by sex (n = 2930)
Females (n = 1487)
CI P Prevalence ratio 95% CI P
–1.92 <0.001 2.51 1.86–3.38 <0.001
–1.21 <0.001 1.44 1.05–1.99 0.02
–2.32 <0.001 2.39 0.59–9.63 0.22
1.00
–0.64 <0.001 0.66 0.53–0.82 <0.001
–1.37 0.97 1.71 1.47–1.99 <0.001
–4.83 <0.001 7.02 3.63–13.59 <0.001
–4.23 0.02 2.30 1.12–4.72 0.02
–2.11 0.82 2.22 1.02–4.81 0.04
1.00
–1.52 0.91 1.78 0.52–6.00 0.36
–1.19 0.18 1.44 0.54–3.86 0.47
Figure 2 Population attributable risk (PAR) among factors associated with COPD in Peru by setting and sex.
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importance of post-treatment pulmonary tuberculosis, a
prevalent disease with worldwide distribution, as a pos-
sible neglected risk factor for COPD in endemic areas.
The prevalence of COPD in Peru was 25% to 70% lower
relative to multi-center studies in other countries [3,11].
In the BOLD study, the prevalence of COPD was 10.1%
for moderate to severe (i.e., GOLD stage II or greater) in
twelve sites from North America, Europe, Asia and Africa
[3]. In the PLATINO study, the prevalence of COPD
ranged from 7.8% to 19.7% in five cities from Brazil, Chile,
Mexico, Uruguay and Venezuela [11]. In the PREPOCOL
study, the prevalence of COPD was 8.9% across five Co-
lombian cities at varying altitudes [13]. A possible reason
for the low prevalence of COPD in our study is also the
low prevalence of daily tobacco smoking: 3% were daily
smokers, with a population attributable risk of COPD due
to tobacco smoking of <10% across all sites for both men
and women. In comparison, every city in the PLATINO
study had a current smoking prevalence of >20% [24]. If
smoking prevalence is low in Peru, this raised the question
of what other determinants are associated with COPD,
and what factors explained heterogeneity between sites.
Utilizing within-country diversity, we evaluated this ques-
tion to direct prevention and management efforts across
settings.Between our sites, we also found considerable variation
in lung function and COPD prevalence. High altitude
areas of urban and rural Puno had notably larger lung cap-
acity as compared to sea level Lima or Tumbes, and sup-
ports past studies on physiological adaptation to high
altitude [25,26]. Despite greater lung capacity and the low-
est rates of smoking, FEV1/FVC was lower at higher alti-
tude vs. sea level settings. The role of high altitude on
COPD has been equivocal: investigators of the PLATINO
study suggested that high altitude contributed to lower
prevalence of COPD, whereas those of the PREPOCOL
study found a higher prevalence of COPD at the high
altitude sites of Colombia [11,13]. In both studies, the
authors noted that changes in FEV1 and FVC among
people who live at high altitude may affect classifica-
tion of obstruction. We also found that high attitude vs.
sea level was associated with a small but relatively greater
increase in FVC compared to FEV1, which may lead
to overestimation of COPD. At the same time, in the
PLATINO and PREPOCOL studies, the highest altitude
cities were Mexico City (2,250 meters above sea level) and
Bogotá (2,640 meters above sea level), respectively, which
are more urbanized than our high altitude setting in Puno
(3,825 meters above sea level). Further research is required
to investigate how altitude affects variation in COPD
prevalence.
Jaganath et al. Respiratory Research  (2015) 16:40 Page 8 of 9In our analysis, we also found that rural residents in
Puno primarily cooked indoors and used biomass fuel
daily. Notably, they had a higher prevalence of COPD
than participants in urban Lima or even urban Puno.
Biomass fuel is associated with a chronic inflammatory
response and ultimately pulmonary damage that increase
the risk of COPD [27,28]. In addition to biomass fuel
smoke exposure, multivariable analysis revealed that a
history of post-treatment pulmonary tuberculosis and
asthma were also associated with COPD, specifically in
our urban settings. Population attributable risks of COPD
between sites further demonstrated the importance of
post-treatment pulmonary tuberculosis and asthma in the
urban setting of Lima. Pulmonary tuberculosis is associ-
ated with lung scarring, bronchial stenosis and paren-
chymal damage that can promote airway obstruction
in endemic areas [4,29]. In the BOLD, PLATINO and
PREPOCOL studies, investigators also found a positive
association between pulmonary tuberculosis and COPD
[5,13,29]. Chronic asthma has been associated with irre-
versible airway obstruction over time, with more rapid de-
cline in FEV1 [4]. For both post-treatment pulmonary
tuberculosis and asthma, further work will need to identify
how their pathogenesis of airway obstruction compares to
other traditional risk factors for COPD such as tobacco
smoking [4], while well-designed prospective studies are
necessary to assess direction of causality.
We also found sex-specific risk factors for COPD,
which suggests that men and women in our setting face
different types and amounts of exposures that impact their
likelihood of disease. Among men, increasing pack years
of smoking was an important determinant of COPD.
While smoking among women was also associated with
COPD, the effect was not significant, and may be a conse-
quence of the low number of women (<2%) who smoked
daily. The population attributable risk of COPD due to to-
bacco smoking was greatest in Tumbes, in particular
among men where the local prevalence of smoking at least
10 pack-years was 10%. Among women, biomass fuel use
at least once daily was also associated with COPD. Men
did not show this trend, and suggests that while all
members of the household were exposed to biomass fuel
smoke, men may have an overall reduced exposure as they
are commonly not the primary cook. A systematic review
found that rural women who used biomass fuels had
greater odds of having COPD [30]. Similarly, we found the
population attributable risk of COPD due to daily expos-
ure to biomass fuel smoke was 55% among women in
rural Puno.
Our study has several strengths. First, our study is a
population-based sample derived from four diverse geo-
graphical and social settings across Peru. Second, we col-
lected extensive demographic, clinical, and behavioral
data while conducting standardized pulmonary functiontests to characterize COPD. Third, the low prevalence of
tobacco smoking provided a unique opportunity for us
to examine other risk factors associated with the preva-
lence of COPD. Our study also has some limitations.
First, we were not powered to determine risk factors
stratified by site. Second, we utilized two commonly used
international reference equations to calculate the
percent-predicted FEV1 and FVC [19,20]; however, the
construction of these reference equations did not include
Peruvians, which affect our estimation of severity categor-
ies. However, we found overall good consistency in the
distributions of severity categories between the two refer-
ence equations. Third, self-reported history of COPD,
post-treatment pulmonary tuberculosis or asthma has lim-
itations compared to direct diagnostic evaluation and may
be underestimated in those without access to care. Fourth,
while sites varied in degree of urbanization and exposure
to biomass fuel smoke and provided a gradient in ambient
air pollution, personal air pollution exposure measure-
ments would have provided a more quantitative com-
parison of differences. Finally, as a cross-sectional
analysis, there are limitations in determining direction of
causality for possible risk factors.
Conclusion
We found that both the prevalence of COPD and risk
factors in Peru varied significantly across settings. Daily
biomass fuel smoke exposure, particularly in rural sites,
was an important cause for this heterogeneity, as com-
pared to differences in tobacco smoking. At the same time,
a history of respiratory disease including post-treatment
pulmonary tuberculosis and asthma were important factors
in urban centers. Overall, we have highlighted unique
aspects of COPD across geographic settings in Peru, to
better understand these determinants, guide future stud-
ies, and implement interventions to reduce the burden of
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